4:15 PM - 4:20 PM Welcome and Introduction
4:20 PM - 4:40 PM Reviewing Recent Advances in ART
4:40 PM - 5:25 PM Expert Guidance on Selecting First-line Therapy and Switch Strategies: Case-Based Discussion
5:25 PM - 5:40 PM Question and Answer Session
5:40 PM - 5:45 PM Conclusions and Closing Thoughts
Date / Time
Congress Center Basel
Jean-Michel Molina, MD, PhD
Head of the Department of Infectious Diseases
Saint-Louis Hospital, Assistance-Publique Hôpitaux de Paris
Professor of Infectious Diseases
University of Paris
José R. Arribas, MD
Research Director (HIV and Infectious Diseases)
Hospital La Paz. IdiPAZ.
Alexandra Calmy, MD, FMH, PhD
HIV/AIDS Unit Director
Infectious Diseases Division
Geneva University Hospitals
University of Geneva
Laura Waters, MD
Consultant Physician, HIV/GU Medicine
Mortimer Market Centre
CNWL NHS Trust
London, United Kingdom
The goal of this activity is to improve learners’ knowledge and competence regarding the integration of newer ARV regimens and paradigms into patient management strategies.
This program is intended for physicians and other healthcare professionals who provide care for patients with HIV infection.
- Apply recent clinical trial data when devising patient care strategies that include newer ARV agents
- Incorporate innovative ARV treatment strategies into the management of persons with HIV infection when appropriate
- Appraise 2-drug vs 3-drug treatment strategies in the care of persons with HIV infection
Joint Accreditation Statement
In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Physician Continuing Medical Education
CCO designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.